WNT/β-catenin pathway is modulated in asthma patients and LPS-stimulated RAW264.7 macrophage cell line

Immunopharmacology and Immunotoxicology

Volumn 34, Issue 1, 2012, Pages 56-65

  Lee, Haeyong ^a   Bae, Sungmin ^a   Choi, Byoung Whui ^a   Yoon, Yoosik ^a  

^a Chung Ang University College of Medicine   (South Korea)

Author keywords

Cytokine; Hyperactivation; IL 6; Inflammation; NF B

Indexed keywords

AXIN; BETA CATENIN; DISHEVELLED 2; GLYCOGEN SYNTHASE KINASE 3BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 6; MESSENGER RNA; SMALL INTERFERING RNA; WNT PROTEIN;

ANIMAL CELL; ARTICLE; ASTHMA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; MACROPHAGE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RNA ANALYSIS; WESTERN BLOTTING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ASTHMA; AXIN PROTEIN; BETA CATENIN; CELL LINE; FEMALE; GLYCOGEN SYNTHASE KINASE 3; HUMANS; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-6; MALE; MICE; NF-KAPPA B; PHOSPHOPROTEINS; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84055190357     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.3109/08923973.2011.574704     Document Type: Article

References (74)

1. Keshav, S., Chung, L.P., Gordon, S. Macrophage products in inflammation. Diagn Microbiol Infect Dis 1990, 13, 439-447.
2. Shibata, N., Glass, C.K. Regulation of macrophage function in inflammation and atherosclerosis. J Lipid Res 2009, 50 Suppl, S277-S281.
3. Paine, R. 3rd, Preston, A.M., Wilcoxen, S., Jin, H., Siu, B.B., Morris, S.B., Reed, J.A., Ross, G., Whitsett, J.A., Beck, J.M. Granulocytemacrophage colony-stimulating factor in the innate immune response to Pneumocystis carinii pneumonia in mice. J Immunol 2000, 164, 2602-2609. (Pubitemid 30115491)
4. Bancroft, G.J., Kelly, J.P., Kaye, P.M., McDonald, V., Cross, C.E. Pathways of macrophage activation and innate immunity. Immunol Lett 1994, 43, 67-70.
5. Trinchieri, G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 1995, 13, 251-276.
6. Yan, Z.Q., Hansson, G.K. Innate immunity, macrophage activation, and atherosclerosis. Immunol Rev 2007, 219, 187-203. (Pubitemid 47390007)
7. Sweet, M.J., Hume, D.A. Endotoxin signal transduction in macrophages. J Leukoc Biol 1996, 60, 8-26. (Pubitemid 26248877)
8. Carter, A.B., Monick, M.M., Hunninghake, G.W. Lipopolysaccharide-induced NF-kappaB activation and cytokine release in human alveolar macrophages is PKC-independent and TK- and PC-PLC-dependent. Am J Respir Cell Mol Biol 1998, 18, 384-391. (Pubitemid 128354096)
9. Kawai, T., Akira, S. TLR signaling. Cell Death Differ 2006, 13, 816-825.
10. Shapira, L., Takashiba, S., Champagne, C., Amar, S., Van Dyke, T.E. Involvement of protein kinase C and protein tyrosine kinase in lipopolysaccharide-induced TNF-alpha and IL-1 beta production by human monocytes. J Immunol 1994, 153, 1818-1824. (Pubitemid 24251127)
11. West, A.P., Koblansky, A.A., Ghosh, S. Recognition and signaling by toll-like receptors. Annu Rev Cell Dev Biol 2006, 22, 409-437.
12. Wright, G., Singh, I.S., Hasday, J.D., Farrance, I.K., Hall, G., Cross, A.S., Rogers, T.B. Endotoxin stress-response in cardiomyocytes: NF-kappaB activation and tumor necrosis factor-alpha expression. Am J Physiol Heart Circ Physiol 2002, 282, H872-H879. (Pubitemid 34654922)
13. Collart, M.A., Baeuerle, P., Vassalli, P. Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B. Mol Cell Biol 1990, 10, 1498-1506.
14. Hiscott, J., Marois, J., Garoufalis, J., D'Addario, M., Roulston, A., Kwan, I., Pepin, N., Lacoste, J., Nguyen, H., Bensi, G. Characterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: evidence for a positive autoregulatory loop. Mol Cell Biol 1993, 13, 6231-6240. (Pubitemid 23292617)
15. Libermann, T.A., Baltimore, D. Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol Cell Biol 1990, 10, 2327-2334.
16. Matsusaka, T., Fujikawa, K., Nishio, Y., Mukaida, N., Matsushima, K., Kishimoto, T., Akira, S. Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc Natl Acad Sci U.S.A. 1993, 90, 10193-10197. (Pubitemid 23328278)
17. Kraus, C., Liehr, T., Hülsken, J., Behrens, J., Birchmeier, W., Grzeschik, K.H., Ballhausen, W.G. Localization of the human beta-catenin gene (CTNNB1) to 3p21: a region implicated in tumor development. Genomics 1994, 23, 272-274.
18. Moon, R.T., Bowerman, B., Boutros, M., Perrimon, N. The promise and perils of Wnt signaling through beta-catenin. Science 2002, 296, 1644-1646. (Pubitemid 34579151)
19. Veeman, M.T., Axelrod, J.D., Moon, R.T. A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling. Dev Cell 2003, 5, 367-377. (Pubitemid 37107667)
20. Wodarz, A., Nusse, R. Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol 1998, 14, 59-88. (Pubitemid 29001449)
21. Cadigan, K.M., Liu, Y.I. Wnt signaling: complexity at the surface. J Cell Sci 2006, 119, 395-402.
22. Willert, K., Nusse, R. Beta-catenin: a key mediator of Wnt signaling. Curr Opin Genet Dev 1998, 8, 95-102.
23. Huelsken, J., Behrens, J. The Wnt signalling pathway. J Cell Sci 2002, 115, 3977-3978. (Pubitemid 35446796)
24. Duan, Y., Liao, A.P., Kuppireddi, S., Ye, Z., Ciancio, M.J., Sun, J. Beta-catenin activity negatively regulates bacteria-induced inflammation. Lab Invest 2007, 87, 613-624. (Pubitemid 46788789)
25. Kim, J.S., Yeo, S., Shin, D.G., Bae, Y.S., Lee, J.J., Chin, B.R., Lee, C.H., Baek, S.H. Glycogen synthase kinase 3beta and betacatenin pathway is involved in toll-like receptor 4-mediated NADPH oxidase 1 expression in macrophages. FEBS J 2010, 277, 2830-2837.
26. Monick, M.M., Carter, A.B., Robeff, P.K., Flaherty, D.M., Peterson, M.W., Hunninghake, G.W. Lipopolysaccharide activates Akt inhuman alveolar macrophages resulting in nuclear accumulation and transcriptional activity of beta-catenin. J Immunol 2001, 166, 4713-4720. (Pubitemid 32233759)
27. Thiele, A., Wasner, M., Müller, C., Engeland, K., Hauschildt, S. Regulation and possible function of beta-catenin in human monocytes. J Immunol 2001, 167, 6786-6793. (Pubitemid 33144169)
28. Wang, H., Garcia, C.A., Rehani, K., Cekic, C., Alard, P., Kinane, D.F., Mitchell, T., Martin, M. IFN-beta production by TLR4-stimulated innate immune cells is negatively regulated by GSK3-beta. J Immunol 2008, 181, 6797-6802.
29. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. Am Rev Respir Dis 1987, 136, 225-244.
30. Bousquet, J., Clark, T.J., Hurd, S., Khaltaev, N., Lenfant, C., O'byrne, P., Sheffer, A. GINA guidelines on asthma and beyond. Allergy 2007, 62, 102-112. (Pubitemid 46091634)
31. Hersperger, R., Buchheit, K.H., Cammisuli, S., Enz, A., Lohse, O., Ponelle, M., Schuler, W., Schweitzer, A., Walker, C., Zehender, H., Zenke, G., Zimmerlin, A.G., Zollinger, M., Mazzoni, L., Fozard, J.R. A locally active antiinflammatory macrolide (MLD987) for inhalation therapy of asthma. J Med Chem 2004, 47, 4950-4957. (Pubitemid 39238270)
32. Weinbrenner, A., Hüneke, D., Zschiesche, M., Engel, G., Timmer, W., Steinijans, V.W., Bethke, T., Wurst, W., Drollmann, A., Kaatz, H.J., Siegmund, W. Circadian rhythm of serum cortisol after repeated inhalation of the new topical steroid ciclesonide. J Clin Endocrinol Metab 2002, 87, 2160-2163. (Pubitemid 34521503)
33. Livak, K.J., Schmittgen, T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 2001, 25, 402-408. (Pubitemid 34164012)
34. Kim, S.Y., Dunn, I.F., Firestein, R., Gupta, P., Wardwell, L., Repich, K., Schinzel, A.C., Wittner, B., Silver, S.J., Root, D.E., Boehm, J.S., Ramaswamy, S., Lander, E.S., Hahn, W.C. CK1epsilon is required for breast cancers dependent on beta-catenin activity. PLoS ONE 2010, 5, e8979.
35. Wang, Y., Liu, S., Zhu, H., Zhang, W., Zhang, G., Zhou, X., Zhou, C., Quan, L., Bai, J., Xue, L., Lu, N., Xu, N. FRAT1 overexpression leads to aberrant activation of beta-catenin/TCF pathway in esophageal squamous cell carcinoma. Int J Cancer 2008, 123, 561-568. (Pubitemid 351898413)
36. Von Asmuth, E.J., Dentener, M.A., Ceska, M., Buurman, W.A. IL-6, IL-8 and TNF production by cytokine and lipopolysaccharidestimulated human renal cortical epithelial cells in vitro. Eur Cytokine Netw 1994, 5, 301-310. (Pubitemid 24212016)
37. Romero, L.I., Schettini, G., Lechan, R.M., Dinarello, C.A., Reichlin, S. Bacterial lipopolysaccharide induction of IL-6 in rat telencephalic cells is mediated in part by IL-1. Neuroendocrinology 1993, 57, 892-897. (Pubitemid 23249934)
38. Jirik, F.R., Podor, T.J., Hirano, T., Kishimoto, T., Loskutoff, D.J., Carson, D.A., Lotz, M. Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells. J Immunol 1989, 142, 144-147. (Pubitemid 19034734)
39. Guha, M., Mackman, N. The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. J Biol Chem 2002, 277, 32124-32132. (Pubitemid 34969025)
40. Diya, Z., Lili, C., Shenglai, L., Zhiyuan, G., Jie, Y. Lipopolysaccharide (LPS) of Porphyromonas gingivalis induces IL-1beta, TNF-alpha and IL-6 production by THP-1 cells in a way different from that of Escherichia coli LPS. Innate Immun 2008, 14, 99-107.
41. Hirotani, T., Lee, P.Y., Kuwata, H., Yamamoto, M., Matsumoto, M., Kawase, I., Akira, S., Takeda, K. The nuclear IkappaB protein IkappaBNS selectively inhibits lipopolysaccharide-induced IL-6 production in macrophages of the colonic lamina propria. J Immunol 2005, 174, 3650-3657. (Pubitemid 40354075)
42. Gray, S., Feinberg, M.W., Hull, S., Kuo, C.T., Watanabe, M., Sen- Banerjee, S., DePina, A., Haspel, R., Jain, M.K. The Krüppel-like factor KLF15 regulates the insulin-sensitive glucose transporter GLUT4. J Biol Chem 2002, 277, 34322-34328.
43. George, S.J. Wnt pathway: a new role in regulation of inflammation. Arterioscler Thromb Vasc Biol 2008, 28, 400-402.
44. Pereira, C.P., Bachli, E.B., Schoedon, G. The wnt pathway: a macrophage effector molecule that triggers inflammation. Curr Atheroscler Rep 2009, 11, 236-242.
45. Gong, R., Rifai, A., Ge, Y., Chen, S., Dworkin, L.D. Hepatocyte growth factor suppresses proinflammatory NFkappaB activation through GSK3beta inactivation in renal tubular epithelial cells. J Biol Chem 2008, 283, 7401-7410.
46. Tetsu, O., McCormick, F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999, 398, 422-426. (Pubitemid 29180374)
47. Shtutman, M., Zhurinsky, J., Simcha, I., Albanese, C., D'Amico, M., Pestell, R., Ben-Ze'ev, A. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci U.S.A. 1999, 96, 5522-5527. (Pubitemid 29234650)
48. Caillaud, D., Evrard, B., Laurichesse, H., Souweine, B. [Role of indoor endotoxins in asthma symptoms]. Rev Mal Respir 2009, 26, 893-899.
49. Kuo Chou, T.N., Li, Y.S., Lue, K.H., Liao, C.F., Lin, C.Y., Tzeng, P.R., Wong, R.H. Genetic polymorphism of manganese superoxide dismutase is associated with childhood asthma. J Asthma 2010, 47, 532-538.
50. Barnes, P.J., Adcock, I.M. Transcription factors and asthma. Eur Respir J 1998, 12, 221-234. (Pubitemid 28325681)
51. Marini, M., Vittori, E., Hollemborg, J., Mattoli, S. Expression of the potent inflammatory cytokines, granulocyte-macrophagecolony- stimulating factor and interleukin-6 and interleukin-8, in bronchial epithelial cells of patients with asthma. J Allergy Clin Immunol 1992, 89, 1001-1009.
52. Kraus-Filarska, M., Malolepszy, J., Medrala, W., Dobek, R. Bacterial lipopolysaccharide-induced sulfidoleukotriene release from peripheral blood leukocytes in patients with asthma and chronic obstructive pulmonary disease. J Investig Allergol Clin Immunol 1998, 8, 94-97. (Pubitemid 28239237)
53. Kawahara, T., Kohjima, M., Kuwano, Y., Mino, H., Teshima-Kondo, S., Takeya, R., Tsunawaki, S., Wada, A., Sumimoto, H., Rokutan, K. Helicobacter pylori lipopolysaccharide activates Rac1 and transcription of NADPH oxidase Nox1 and its organizer NOXO1 in guinea pig gastric mucosal cells. Am J Physiol Cell Physiol 2005, 288, C450-C457. (Pubitemid 40105357)
54. Lee, J.G., Lim, E.J., Park, D.W., Lee, S.H., Kim, J.R., Baek, S.H. A combination of Lox-1 and Nox1 regulates TLR9-mediated foam cell formation. Cell Signal 2008, 20, 2266-2275.
55. Rokutan, K., Kawahara, T., Kuwano, Y., Tominaga, K., Sekiyama, A., Teshima-Kondo, S. NADPH oxidases in the gastrointestinal tract: a potential role of Nox1 in innate immune response and carcinogenesis. Antioxid Redox Signal 2006, 8, 1573-1582. (Pubitemid 44726332)
56. Akashi, K., Hayashi, S., Gondo, H., Mizuno, S., Harada, M., Tamura, K., Yamasaki, K., Shibuya, T., Uike, N., Okamura, T. Involvement of interferon-gamma and macrophage colony-stimulating factor in pathogenesis of haemophagocytic lymphohistiocytosis in adults. Br J Haematol 1994, 87, 243-250.
57. Cline, M.J. Histiocytes and histiocytosis. Blood 1994, 84, 2840-2853. (Pubitemid 24328071)
58. Osugi, Y., Hara, J., Tagawa, S., Takai, K., Hosoi, G., Matsuda, Y., Ohta, H., Fujisaki, H., Kobayashi, M., Sakata, N., Kawa-Ha, K., Okada, S., Tawa, A. Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis. Blood 1997, 89, 4100-4103. (Pubitemid 27220957)
59. Nakagawa, R., Naka, T., Tsutsui, H., Fujimoto, M., Kimura, A., Abe, T., Seki, E., Sato, S., Takeuchi, O., Takeda, K., Akira, S., Yamanishi, K., Kawase, I., Nakanishi, K., Kishimoto, T. SOCS-1 participates in negative regulation of LPS responses. Immunity 2002, 17, 677-687. (Pubitemid 35351512)
60. Mashima, R., Saeki, K., Aki, D., Minoda, Y., Takaki, H., Sanada, T., Kobayashi, T., Aburatani, H., Yamanashi, Y., Yoshimura, A. FLN29, a novel interferon- and LPS-inducible gene acting as a negativeregulator of toll-like receptor signaling. J Biol Chem 2005, 280, 41289-41297. (Pubitemid 41832185)
61. Kidd, P. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev 2003, 8, 223-246. (Pubitemid 37099886)
62. Crane, I.J., Forrester, J.V. Th1 and Th2 lymphocytes in autoimmune disease. Crit. Rev. Immunol. 2005, 25, 75-102. (Pubitemid 40910583)
63. Larché, M., Robinson, D.S., Kay, A.B. The role of T lymphocytes in the pathogenesis of asthma. J Allergy Clin Immunol 2003, 111, 450-63; quiz 464. (Pubitemid 36337859)
64. Maggi, E. The TH1/TH2 paradigm in allergy. Immunotechnology 1998, 3, 233-244. (Pubitemid 28098326)
65. Diehl, S., Rincón, M. The two faces of IL-6 on Th1/Th2 differentiation. Mol Immunol 2002, 39, 531-536. (Pubitemid 35341492)
66. Yachida, M., Kurokohchi, K., Arima, K., Nishioka, M. Increased bcl-2 expression in lymphocytes and its association with hepatocellular damage in patients with autoimmune hepatitis. Clin Exp Immunol 1999, 116, 140-145. (Pubitemid 29170017)
67. Ye, B.H., Cattoretti, G., Shen, Q., Zhang, J., Hawe, N., de Waard, R., Leung, C., Nouri-Shirazi, M., Orazi, A., Chaganti, R.S., Rothman, P., Stall, A.M., Pandolfi, P.P., Dalla-Favera, R. The BCL-6 protooncogene controls germinal-centre formation and Th2-type inflammation. Nat Genet 1997, 16, 161-170.
68. Chalaris, A., Garbers, C., Rabe, B., Rose-John, S., Scheller, J. The soluble interleukin 6 receptor: generation and role in inflammation and cancer. Eur J Cell Biol 2010; DOI10.1016.
69. Rabe, B., Chalaris, A., May, U., Waetzig, G.H., Seegert, D., Williams, A.S., Jones, S.A., Rose-John, S., Scheller, J. Transgenic blockade of interleukin 6 transsignaling abrogates inflammation. Blood 2008,111, 1021-1028. (Pubitemid 351213379)
70. Rose-John, S., Waetzig, G.H., Scheller, J., Grötzinger, J., Seegert, D. The IL-6/sIL-6R complex as a novel target for therapeutic approaches. Expert Opin Ther Targets 2007, 11, 613-624. (Pubitemid 46730080)
71. Doganci, A., Sauer, K., Karwot, R., Finotto, S. Pathological role of IL-6 in the experimental allergic bronchial asthma in mice. Clin Rev Allergy Immunol 2005, 28, 257-270.
72. Whiteley, W., Jackson, C., Lewis, S., Lowe, G., Rumley, A., Sandercock, P., Wardlaw, J., Dennis, M., Sudlow, C. Inflammatory markers and poor outcome after stroke: a prospective cohort study and systematic review of interleukin-6. PLoS Med 2009, 6, e1000145.
73. Tso, A.R., Merino, J.G., Warach, S. Interleukin-6 174G/C polymorphism and ischemic stroke: a systematic review. Stroke 2007, 38, 3070-3075. (Pubitemid 350035706)
74. Imanifooladi, A.A., Yazdani, S., Nourani, M.R. The role of nuclear factor-kappaB in inflammatory lung disease. Inflamm Allergy Drug Targets 2010, 9, 197-205.